CIK 0001534120 · Non-accelerated filer<br>Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450705648
- Phone
- 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,865,893
- in 5 filings, $1.9M under 10b5-1 plans
Net −$1,865,893. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-23 | Doyle Mittie Chief Medical Officer | Option exercise 10b5-1 | +1,450 | $8.04 | $12K | 53,226 |
| 2026-06-23 | Doyle Mittie Chief Medical Officer | Sale 10b5-1 | −1,450 | $18.00 | $26K | 51,776 |
| 2026-06-23 | Doyle Mittie Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,450 | 116,871 | ||
| 2026-06-10 | Riley Jennifer Chief Strategy Officer | Shares withheld for taxes | −588 | $13.10 | $8K | 39,696 |
| 2026-06-10 | Doyle Mittie Chief Medical Officer | Shares withheld for taxes | −1,084 | $13.10 | $14K | 51,776 |
| 2026-06-10 | Sullivan Christopher Ryan Chief Financial Officer | Shares withheld for taxes | −138 | $13.10 | $2K | 40,773 |
| 2026-06-10 | VARKI PAUL Chief Legal Officer | Shares withheld for taxes | −1,081 | $13.10 | $14K | 32,576 |
| 2026-06-02 | Truex Samantha Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2026-06-02 | KANTOFF AARON Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2026-06-02 | Jain Rita Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2026-06-02 | Lind Kevin Robert Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2026-06-02 | Heffernan Michael Thomas Director | Grant or award · Stock Option (Right to Buy) | +29,500 | 29,500 | ||
| 2026-06-02 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2026-05-28 | Doyle Mittie Chief Medical Officer | Option exercise 10b5-1 | +679 | $8.04 | $5K | 47,801 |
| 2026-05-28 | Doyle Mittie Chief Medical Officer | Sale 10b5-1 | −679 | $16.00 | $11K | 47,122 |
| 2026-05-28 | Doyle Mittie Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −679 | 118,321 | ||
| 2026-05-21 | Riley Jennifer Chief Strategy Officer | Grant or award | +34,200 | 36,855 | ||
| 2026-05-21 | Doyle Mittie Chief Medical Officer | Grant or award | +43,500 | 47,122 | ||
| 2026-05-21 | Sullivan Christopher Ryan Chief Financial Officer | Grant or award | +39,900 | 40,323 | ||
| 2026-05-21 | VARKI PAUL Chief Legal Officer | Grant or award | +24,300 | 27,934 |
Page 3 of 11 · 202 trades